L-carnitine and neuroprotection in the animal model of mitochondrial dysfunction

Annals of the New York Academy of Sciences

Volumn 1053, Issue , 2005, Pages 174-182

  Binienda, Zbigniew ^a,c   Przybyla Zawislak, Beata ^a   Virmani, Ashraf ^b   Schmued, Larry ^a  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

^b Sigma Tau SpA   (Italy)

^c CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

3 nitropropionic acid; Carnitine; Mitochondria; Neuro protection; Striatum

Indexed keywords

3 NITROPROPIONIC ACID; CARNITINE; MYCOTOXIN; PLANT TOXIN; REACTIVE OXYGEN METABOLITE; SUCCINATE DEHYDROGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; BRAIN BLOOD FLOW; CITRIC ACID CYCLE; CONFERENCE PAPER; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ELECTRON TRANSPORT; ENZYME INHIBITION; GLYCOLYSIS; HYPOTHERMIA; MALE; MITOCHONDRIAL MEMBRANE; NERVE DEGENERATION; NERVE INJURY; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; RAT;

ANIMALIA;

EID: 29744462142     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1344.015     Document Type: Conference Paper

References (29)

1. WALLACE, D.C. 1999. Mitochondrial diseases in man and mouse. Science 283:1482-1488.
2. LINNANE, A.W., S. MARZUH, T. OZAWA et al. 1989. Mitochondrial DNA mutations as an important contributor to ageing and degenerative diseases. Lancet 1: 642-645.
3. BEAL, M.F. 2003. Mitochondria, oxidative damage, and inflammation in Parkinson's disease. Ann. N.Y. Acad. Sci. 991: 120-131.
4. ZEEVALK, G.D., E. DERR-YELLIN & W.J. NICKLAS. 1995. Relative vulnerability of dopamine and GABA neurons in mesencephalic culture to inhibition of succinate dehydrogenase by malonate and 3-nitropropionic acid and protection by NMDA receptor blockade. J. Pharmacol. Exp. Ther. 275: 1124-1130.
5. ALSTON, T.A., L. MELA & H.J. BRIGHT. 1977. 3-Nitropropionate, the toxic substance of Indigofera, is a suicide inactivator of succinate dehydrogenase. Proc. Natl. Acad. Sci. USA 74: 3767-3771.
6. HAMILTON, B.F. & D.H. GOULD. 1987. Nature and distribution of brain lesions in rats intoxicated with 3-nitropropionic acid: a type of hypoxic (energy deficient) brain damage. Acta Neuropathol. 72: 286-297.
7. BINIENDA, Z., D.L. FREDERICK, S.A. FERGUSON et al. 1995. The effects of perinatal hypoxia on the behavioral, neurochemical, and neurohistological toxicity of the metabolic inhibitor 3-nitropropionic acid. Metab. Brain Dis. 10: 269-282.
8. LUDOLPH, A., M. SEELING, A. LUDOLPH et al. 1992. 3-Nitropropionic acid-exogenous animal neurotoxin and possible human striatal toxin. Can. J. Neurol. Sci. 18: 492-498.
9. BORLONGAN, C.V., T.K. KOUTOUZIS, T.B. FREEMAN et al. 1996. Behavioral pathology induced by repeated systemic injections of 3-nitropropionic acid mimics the motoric symptoms of Huntington's disease. Brain Res. 697: 254-257.
10. BORLONGAN, C., T. SHIMIZU & P.R. SANBERG. 2000. Comparative study on 3-nitro-propionic acid neurotoxicity. In Mitochondrial and Neurodegenerative Disorders, pp. 93-106. Humana Press. Totowa, NJ.
11. BINIENDA, Z. & C.S. KIM. 1997. Increase in levels of total free fatty acids in rat brain regions following 3-nitropropionic acid administration. Neurosci. Lett. 230: 199-201.
12. BINIENDA, Z., C. SIMMONS, S. HUSSAIN et al. 1998. Effect of acute exposure to 3-nitro-propionic acid on activities of endogenous antioxidants in the rat brain. Neurosci. Lett. 251: 173-176.
13. NONY, P.A., A.C. SCALLET, R.L. ROUNTREE et al. 1999. 3-Nitropropionic acid (3-NPA) produces hypothermia and inhibits histochemical labelling of succinate dehydrogenase (SDH) in rat brain. Metab. Brain Dis. 14: 83-94.
14. BINIENDA, Z. 2003. Neuroprotective effects of L-carnitine in induced mitochondrial dysfunction. Ann. N.Y. Acad. Sci. 993: 289-295.
15. BINIENDA, Z., B. PRZYBYLA-ZAWISLAK, J. SUMMAGE et al. 2003. Soc. Neurosci. Abstr. no. 539.9.
16. Di LISA, F. 2002. Biochemical and pharmacological relevance of carnitine. Riv. Ital. Nutr. Parent. Enter. 20: 1-10.
17. VIRMANI, A. & Z. BINIENDA. 2004. Role of carnitine esters in brain neuropathology. Mol. Asp. Med. 25: 533-549.
18. ARDUINI, A., N. DENISOVA, M.A. VIRMANI et al. 1994. Evidence for the involvement of carnitine-dependent long-chain acyltransferases in neuronal triacylglycerol and phospholipid fatty acid turnover. J. Neurochem. 62: 1530-1538.
19. KUMARAN, S., B. DEEPAK, B. NAVEEN et al. 2003. Effects of levocarnitine on mitochondrial antioxidant systems and oxidative stress in aged rats. Drugs RD 4: 141-147.
20. VIRMANI, A., R. BISELLI, A. SPADONI et al. 1995. Protective actions of L-carnitine and acetyl-L-carnitine on the neurotoxicity evoked by mitochondrial uncoupling or inhibitors. Pharmacol. Res. 32: 383-389.
21. BINIENDA, Z., J.R. JOHNSON, A.A. TYLER-HASHEMI et al. 1999. Protective effect of L-carnitine in the neurotoxicity induced by the mitochondrial inhibitor 3-nitro-propionic acid (3-NPA). Ann. N.Y. Acad. Sci. 890: 173-178.
22. BINIENDA, Z. & S.F. ALI. 2001. Neuroprotective role of L-carnitine in the 3-nitro-propionic acid induced neurotoxicity. Tox. Lett. 125: 67-73.
23. BROUILLET, E., B.G. JENKINS, B.T. HYMAN et al. 1993. Age-dependent vulnerability of the striatum to the mitochondrial toxin 3-nitropropionic acid. J. Neurochem. 60: 356-359.
24. SCHMUED, L.C. & K.J. HOPKINS. 2000. Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration. Brain Res. 874: 123-130.
25. ROSADINI, G., S. MARENCO, F. NOBILI et al. 1990. Acute effects of acetyl-L-carnitine on regional cerebral blood flow in patients with brain ischaemia. Int. J. Clin. Pharmacol. Res. 10: 123-128.
26. BRECHER, P. 1983. The interaction of long chain acyl CoA with membranes. Mol. Cell Biochem. 139: S115-S119.
27. PANG, Z. & J.W. GEDDES. 1997. Mechanisms of cell death induced by the mitochondrial toxin 3-nitropropionic acid: acute excitotoxic necrosis and delayed apoptosis. J. Neurosci. 17: 3064-3073.
28. WIECKOWSKI, M.R., D. BRDICZKA & L. WOJTCZAK. 2000. Long-chain fatty acids promote opening of the reconstituted mitochondrial permeability transition pore. FEBS Lett. 484: 61-64.
29. 3- and fatty acid-induced membrane permeability transition by L-carnitine. Comp. Biochem. Physiol. B130: 411-418.